40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
168.96%
Revenue growth above 1.5x MTDR's 96.42%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2212.00%
Gross profit growth above 1.5x MTDR's 408.88%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
129.91%
EBIT growth 1.25-1.5x MTDR's 116.61%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
129.91%
Operating income growth 1.25-1.5x MTDR's 116.61%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
152.75%
Net income growth 1.25-1.5x MTDR's 111.27%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
152.11%
EPS growth 1.25-1.5x MTDR's 111.30%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
152.26%
Diluted EPS growth 1.25-1.5x MTDR's 111.30%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
1.40%
Share count expansion well above MTDR's 1.45%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.99%
Diluted share count expanding well above MTDR's 1.49%. Michael Burry would fear significant dilution to existing owners' stakes.
16.55%
Dividend growth of 16.55% while MTDR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
124.10%
OCF growth above 1.5x MTDR's 50.00%. David Dodd would confirm a clear edge in underlying cash generation.
85.61%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
-76.47%
Negative 10Y revenue/share CAGR while MTDR stands at 300.63%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-64.31%
Negative 5Y CAGR while MTDR stands at 115.14%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-39.50%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-89.40%
Negative 10Y OCF/share CAGR while MTDR stands at 265.13%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-88.07%
Negative 5Y OCF/share CAGR while MTDR is at 43.86%. Joel Greenblatt would question the firm’s operational model or cost structure.
-82.89%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-78.00%
Negative 10Y net income/share CAGR while MTDR is at 93.39%. Joel Greenblatt sees a major red flag in long-term profit erosion.
126.62%
Positive 5Y CAGR while MTDR is negative. John Neff might view this as a strong mid-term relative advantage.
45.04%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-68.23%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-67.75%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-0.97%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-84.68%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.41%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-89.55%
Negative near-term dividend growth while MTDR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
50.63%
AR growth well above MTDR's 24.20%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-2.34%
Negative asset growth while MTDR invests at 8.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
25.25%
BV/share growth above 1.5x MTDR's 2.13%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-20.74%
We’re deleveraging while MTDR stands at 16.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-3.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.